Keudell Zoetis Inc. Transaction History

Keudell

$366 Million
Q3 2024

A detailed history of Keudell transactions in Zoetis Inc. stock. As of the latest transaction made, Keudell holds 1,576 shares of ZTS stock, worth $259,409. This represents 0.08% of its overall portfolio holdings.

Number of Shares

1,576

Previous 1,490 5.77%

Holding current value

$259,409

Previous $258,000 18.99%

% of portfolio

0.08%

Previous 0.08%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$172.58 - $196.48 $14,841 - $16,897	86 Added 5.77%	1,576 $307,000
Q2 2024 Jul 16, 2024	SELL	$145.54 - $178.83 $15,718 - $19,313	-108 Reduced 6.76%	1,490 $258,000
Q1 2024 May 07, 2024	BUY	$165.67 - $199.94 $49,038 - $59,182	296 Added 22.73%	1,598 $270,000
Q4 2023 Feb 14, 2024	SELL	$151.44 - $200.09 $908 - $1,200	-6 Reduced 0.46%	1,302 $256,000
Q3 2023 Oct 18, 2023	SELL	$167.14 - $192.77 $25,739 - $29,686	-154 Reduced 10.53%	1,308 $227,000
Q2 2023 Jul 20, 2023	BUY	$160.94 - $186.23 $643 - $744	4 Added 0.27%	1,462 $251,000
Q1 2023 Apr 18, 2023	SELL	$145.48 - $175.02 $13,238 - $15,926	-91 Reduced 5.87%	1,458 $242,000
Q4 2022 Jan 20, 2023	SELL	$131.14 - $157.47 $25,310 - $30,391	-193 Reduced 11.08%	1,549 $0
Q3 2022 Oct 12, 2022	SELL	$148.29 - $182.55 $100,540 - $123,768	-678 Reduced 28.02%	1,742 $258,000
Q2 2022 Jul 18, 2022	SELL	$155.97 - $200.09 $434,844 - $557,850	-2,788 Reduced 53.53%	2,420 $416,000
Q1 2022 Apr 18, 2022	BUY	$181.39 - $234.03 $333,757 - $430,615	1,840 Added 54.63%	5,208 $982,000
Q4 2021 Feb 08, 2022	SELL	$193.69 - $247.03 $39,900 - $50,888	-206 Reduced 5.76%	3,368 $822,000
Q3 2021 Oct 20, 2021	SELL	$189.29 - $209.69 $92,562 - $102,538	-489 Reduced 12.04%	3,574 $694,000
Q2 2021 Jul 13, 2021	SELL	$155.9 - $187.99 $84,341 - $101,702	-541 Reduced 11.75%	4,063 $757,000
Q1 2021 Apr 13, 2021	SELL	$144.0 - $169.39 $66,096 - $77,750	-459 Reduced 9.07%	4,604 $725,000
Q4 2020 Feb 12, 2021	SELL	$157.07 - $174.35 $4,712 - $5,230	-30 Reduced 0.59%	5,063 $838,000
Q3 2020 Oct 20, 2020	SELL	$137.1 - $165.37 $729,646 - $880,099	-5,322 Reduced 51.1%	5,093 $842,000
Q2 2020 Jul 14, 2020	BUY	$111.92 - $142.53 $607,166 - $773,225	5,425 Added 108.72%	10,415 $1.44 Million
Q1 2020 Apr 20, 2020	SELL	$92.66 - $144.94 $73,664 - $115,227	-795 Reduced 13.74%	4,990 $587,000
Q4 2019 Jan 29, 2020	SELL	$116.25 - $133.25 $38,595 - $44,239	-332 Reduced 5.43%	5,785 $766,000
Q3 2019 Nov 13, 2019	BUY	$112.57 - $128.43 $3,039 - $3,467	27 Added 0.44%	6,117 $762,000
Q2 2019 Aug 23, 2019	BUY	$97.98 - $114.28 $596,698 - $695,965	6,090 New	6,090 $736,000
Q2 2019 Aug 21, 2019	SELL	$97.98 - $114.28 $618,057 - $720,878	-6,308 Closed	0 $0
Q1 2019 Aug 21, 2019	BUY	$81.56 - $100.67 $514,480 - $635,026	6,308 New	6,308 $635,000

Others Institutions Holding ZTS

# of Institutions

1,957

Shares Held

410M

Call Options Held

1.02M

Put Options Held

1.09M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $77.1B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keudell, based on Form 13F filings with the SEC.

News

Stay updated on Keudell with notifications on news.

Account